dr. ruan on stratifying risk in mcl
Published 4 years ago • 57 plays • Length 1:03Download video MP4
Download video MP3
Similar videos
-
1:22
dr. ruan on unanswered questions regarding treatment decisions in mcl
-
1:12
dr. ruan discusses biomarkers in mcl
-
0:56
dr. ruan on lenalidomide plus rituximab in mcl
-
1:17
dr. ruan on long-term findings with lenalidomide plus rituximab in mcl
-
0:58
dr. jia ruan discusses lenalidomide plus rituximab in mcl
-
2:16
dr. ruan discusses btk inhibitors in mcl
-
10:42
understanding mantle cell lymphoma with jia ruan, md, ph.d.
-
9:14
case of the week: perihilar cholangiocarcinoma/klatskin tumor (ct & mri)
-
2:49
defensil®-pure eco: discover the secret of postbiotic skin care for sensitive skin ┃ rahn ag
-
3:30
risk assessment and prognosis in mcl
-
1:23
dr. rule on the future treatment paradigm in mcl
-
2:00
dr. rule on standard of care in mcl
-
5:10
risk classification and assessment in follicular lymphoma
-
1:22
dr. lee on the mechanism of action of cirmtuzumab in mcl or cll
-
2:09
dr. ruan on the utility of molecular profiling in mantle cell lymphoma
-
1:31
dr. wang on the efficacy of kte-x19 in low- and high-risk r/r mcl
-
6:56
emerging therapies in mcl: the promise of immunotherapies
-
0:55
dr. phillips discusses novel treatment regimen in mcl
-
1:06
dr. phillips on the safety of acalabrutinib plus bendamustine/rituximab in mcl
-
6:38
risk stratification in renal cell carcinoma
-
4:15
advances being made in the treatment of mcl: personalized therapy and combination approaches
-
6:08
risk stratified treatment; maintenance or not?